GlassScriptPhysician profile
Leah Nelson
NPI 1104191055
$2,577.36
in general payments reported to CMS, 2019-2025
20 companies · $670 in 2025
The $670 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.92 · 2022: $130 · 2023: $1,194 · 2024: $555 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,419.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $513.46 | 2022-2025 | |
| Edwards Lifesciences Corporation | $354.45 | 2023-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $343.95 | 2023 | Watchman Access System, Vigilant X4 Crt-D |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.40 | 2022-2025 | Lifevest |
| Abbott Laboratories | $159.38 | 2021-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $153.14 | 2022-2023 | Xarelto |
| Novo Nordisk INC | $150.80 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Heartflow, INC. | $147.48 | 2025 | |
| Alnylam Pharmaceuticals INC. | $110.04 | 2022-2025 | Onpattro, Amvuttra |
| Amgen INC. | $86.33 | 2022-2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $67.55 | 2025 | |
| Novartis Pharmaceuticals Corporation | $53.28 | 2022-2025 | |
| Daiichi Sankyo INC. | $52.44 | 2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.70 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $45.39 | 2023-2024 | Farxiga, Brilinta |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $37.67 | 2025 | Ecc Solutions, Mcot |
| Inspire Medical Systems, INC. | $26.81 | 2023 | Inspire |
| Thrombolex, INC. | $25.35 | 2025 | Bashir Endovascular Catheter |
| Atricure, INC. | $22.63 | 2023 | |
| Merck Sharp & Dohme LLC | $13.11 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.